Search
for
Sort by
Research 181–210 of 263
- Safety of testosterone treatment in postmenopausal women
- Therapeutic strategy for hair regeneration: hair cycle activation, niche environment modulation, wound-induced follicle neogenesis, and stem cell engineering
- Male gonadal function in coeliac disease: 2. Sex hormones.
- Management of Hirsutism
- 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Clinical biochemistry of dihydrotestosterone
- 5α-Reduced glucocorticoids: a story of natural selection
- Ornithine decarboxylase is upregulated by the androgen receptor in skeletal muscle and regulates myoblast proliferation
- Intracrine and Myotrophic Roles of 5α-Reductase and Androgens
- Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
- Mechanism of action of androgen in hair follicles
- 13C-NMR study of 4-azasteroids in solution and solid state
- Rooster feathering, androgenic alopecia, and hormone-dependent tumor growth: What is in common?
- Intermittent Low-Dose Finasteride Administration Is Effective for Treatment of Hirsutism in Adolescent Girls: A Pilot Study
- Management of Androgenetic Alopecia
- Levonorgestrel effects on serum androgens, sex hormone–binding globulin levels, hair shaft diameter, and sexual function
- Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients
- Inhibition of Hair Growth by Testosterone in the Presence of Dermal Papilla Cells from the Frontal Bald Scalp of the Postpubertal Stumptailed Macaque
- Hormonal regulation in male androgenetic alopecia—Sex hormones and beyond: Evidence from recent genetic studies
- Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes
- Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Early embryonic exposure of freshwater gastropods to pharmaceutical 5-alpha-reductase inhibitors results in a surprising open-coiled “banana-shaped” shell
- Establishment of type II 5α-reductase over-expressing cell line as an inhibitor screening model
- A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia
- A comment on the post-finasteride syndrome
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- New Insights into Testosterone Biosynthesis: Novel Observations from HSD17B3 Deficient Mice